Teduglutide in short bowel syndrome patients: A way back to normal life?

BACKGROUND: The glucagon‐like peptide 2 analogue teduglutide is an effective drug for the treatment of short bowel syndrome patients with intestinal failure (SBS‐IF). This intestinotrophic peptide improves intestinal capacity for fluid and nutrient absorption through induction of mucosal growth and...

Descripción completa

Detalles Bibliográficos
Autores principales: Harpain, Felix, Schlager, Lukas, Hütterer, Elisabeth, Dawoud, Christopher, Kirchnawy, Sabine, Stift, Judith, Krotka, Pavla, Stift, Anton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298195/
https://www.ncbi.nlm.nih.gov/pubmed/34614239
http://dx.doi.org/10.1002/jpen.2272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298195/
https://www.ncbi.nlm.nih.gov/pubmed/34614239
http://dx.doi.org/10.1002/jpen.2272

Ejemplares similares